[Federal Register Volume 63, Number 29 (Thursday, February 12, 1998)]
[Notices]
[Page 7181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-3611]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 8, 1997, Johnson & 
Johnson Pharmaceutical Partners, HC-02 State Road 933, KMO.1 Mamey Ward 
HC-02 Box 19250, Gurabo, Puerto Rico 00778-9629, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of sufentanil (9740), a basic class of 
controlled substance listed in Schedule II.
    The firm plans to manufacture sufentanil for bulk distribution to 
its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 13, 1998.

    Dated: January 21, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-3611 Filed 2-11-98; 8:45 am]
BILLING CODE 4410-09-M